Disc Medicine IRON Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $170.64M+76.5% | $96.67M+39.6% | $69.26M+107% | $33.44M— | ||
| $65.38M+97.8% | $33.05M+51.2% | $21.86M— | —— | ||
| $236.02M+81.9% | $129.72M+42.4% | $91.13M+91.9% | $47.48M— | ||
| $3.61M+531% | $572K— | $0— | —— | ||
| $24.2M+16.8% | $20.72M+40.0% | $14.8M+2,183% | $648K+113% | ||
| $361K+1.7% | $355K+259% | $99K— | $0— | ||
| -$212.18M-94.0% | -$109.36M-43.1% | -$76.43M-63.2% | -$46.83M— | ||
| -$5.99-50.1% | -$3.99-14.3% | -$3.49+92.2% | -$44.95-9.7% | ||
| -$235.74M-81.9% | -$129.56M-42.3% | -$91.03M-92.1% | -$47.39M— | ||
| -$236.02M-81.9% | -$129.72M-42.4% | -$91.13M-91.9% | -$47.48M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.